Poster: A Sensitive and Specific Human Primary Stem Cell-Based In Vitro Assay for Predicting The Gastrointestinal Toxicity Risk of Therapeutic Agents

GI Toxicities are the most common drug-induced adverse events in human clinical trials and are poorly predicted by rodent models. View our poster presentation from 2023 SOT meeting authored by James Levi describing how a new human-derived cell model provides an efficient and informative screen for drug effects on intestinal cell proliferation and barrier function toxicities while closely resembling natural human physiology.

Share this article with a friend